Lack of Primary Mutations Associated With Integrase Inhibitors Among HIV-1 Subtypes B, C, and F Circulating in Brazil | Zendy

Caroline Passaes | Zendy; Monick Lindenmeyer Guimarães | Zendy; Saada Lima Chequer Fernandez | Zendy; Roberta dos Santos Lorete | Zendy; Sylvia Lopes Maia Teixeira | Zendy; José Carlos Couto-Fernandez | Zendy; Mariza Gonçalves Morgado | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Lack of Primary Mutations Associated With Integrase Inhibitors Among HIV-1 Subtypes B, C, and F Circulating in Brazil

Author(s) -

Caroline Passaes,

Monick Lindenmeyer Guimarães,

Saada Lima Chequer Fernandez,

Roberta dos Santos Lorete,

Sylvia Lopes Maia Teixeira,

José Carlos Couto-Fernandez,

Mariza Gonçalves Morgado

Publication year - 2009

Publication title -

jaids journal of acquired immune deficiency syndromes

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.162

H-Index - 157

eISSN - 1944-7884

pISSN - 1525-4135

DOI - 10.1097/qai.0b013e31819df3b3

Subject(s) - elvitegravir , raltegravir , integrase , virology , integrase inhibitor , biology , drug resistance , resistance mutation , reverse transcriptase , mutation , lentivirus , polymerase chain reaction , genetics , human immunodeficiency virus (hiv) , viral load , antiretroviral therapy , gene , viral disease

Antiretroviral drugs targeting integrase (IN) have recently been approved for use in combined and salvage therapeutic interventions.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research